18:00 , May 11, 2018 |  BC Week In Review  |  Financial News

AxoGen raises $123M in upsized follow-on

AxoGen Inc. (NASDAQ:AXGN) raised $123 million on May 9 through the sale of 3 million shares at $41 in an upsized follow-on underwritten by Jefferies, Leerink Partners, William Blair and JMP Securities. The price is...
18:07 , May 9, 2018 |  BC Extra  |  Financial News

AxoGen raises $123M in upsized follow-on

AxoGen Inc. (NASDAQ:AXGN) raised $123 million through the sale of 3 million shares at $41 in an upsized follow-on underwritten by Jefferies, Leerink Partners, William Blair and JMP Securities. The price is a 5% discount...
07:00 , Aug 12, 2013 |  BioCentury  |  Finance

Highlights of weekly biotech stock moves

Regulatory milestones Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) was down $1.43 to $18.43 last week after disclosing that FDA denied breakthrough therapy designation for AP26113 for anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC). Ariad said...
23:35 , Aug 9, 2013 |  BC Extra  |  Financial News

AxoGen, Tonix raise money in follow-ons, list on NASDAQ

Neurology companies AxoGen Inc. (NASDAQ:AXGN) and Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) raised almost $30 million in follow-ons on Friday and began trading on NASDAQ after delisting from the OTCQB. AxoGen raised $18 million through the...
07:00 , Oct 15, 2012 |  BC Week In Review  |  Company News

AxoGen Inc., PDL BioPharma deal

PDL purchased high single-digit royalties on AxoGen's product revenues over the next eight years for $20.8 million in cash. The deal includes minimum payments beginning in 4Q14. PDL has the right to require AxoGen to...
07:00 , Jul 23, 2012 |  BC Week In Review  |  Company News

AxoGen Inc. sales and marketing update

AxoGen said partner MD for Life S.r.l. (Catania, Italy) launched Avance Nerve Graft for bridging nerve discontinuities in Italy. The product is decellularized allograft nerves recovered from cadaveric donors. MD for Life has distribution rights...
07:00 , Mar 16, 2009 |  BC Week In Review  |  Clinical News

AVANCE Nerve Graft neurology data

Data from 9 patients with digital nerve injuries showed that AVANCE Nerve Graft restored nerve sensation to near normal levels within 9 months of implantation. Functional recovery was observed with graft lengths of up to...